A firewall against relapse — adjuvant immunotherapy steps into the spotlight for resected Merkel cell carcinoma.

To provide the information your oncologist is not telling you or doesn't have the time to!
Stay Informed About the Latest Oncology Breakthroughs
Explore the forefront of oncological research with our “Research Advances” category. Discover cutting-edge studies, innovative treatments, and scientific insights into cancer. Stay up-to-date with the latest breakthroughs and advancements in the field of oncology to make informed decisions about your health or that of your loved ones. Dive into the world of scientific progress and gain a deeper understanding of how research is shaping the future of cancer care.

A firewall against relapse — adjuvant immunotherapy steps into the spotlight for resected Merkel cell carcinoma.

Protecting vision, preserving the person — the promise of ocular-sparing oncology.

Details once dismissed as trivial—like timing—can quietly reshape cancer care.

Sometimes restraint is the wiser choice — half of patients are cured with PD-1 alone.

When innovation meets immune activation, new possibilities emerge for melanoma care.

Targeting PRAME with TCR-T cell therapy may mark a new era for immunotherapy in melanoma and beyond.

The CHALLENGE trial proves what we’ve long suspected: structured exercise isn’t just good for you—it can save your life.

When immune therapy clears cancer, the real question for resectable tumors becomes: Do we still need to resect?

From early-stage to brain metastases, ASCO’s latest melanoma abstracts spotlight the growing power of targeted and immune-based therapies across disease stages.

ctDNA is helping us track what truly matters—real-time, personalized signals that guide smarter decisions in cancer care.